Yes, a Japanese Designated Marketing Authorization Holder (DMAH) typically conducts distributor audits to ensure compliance with regulatory requirements and quality standards. These audits assess the distributor’s adherence to Good Distribution Practices (GDP) and contractual obligations, ensuring the safe and effective distribution of pharmaceutical products within Japan’s regulatory framework.
